ADME Sciences, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA.
College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Clin Pharmacol Ther. 2021 Jul;110(1):248-258. doi: 10.1002/cpt.2244. Epub 2021 Apr 18.
Liver-derived small extracellular vesicles (sEVs), prepared from small sets of banked serum samples using a novel two-step protocol, were deployed as liquid biopsy to study the induction of cytochromes P450 (CYP3A4, CYP3A5, and CYP2D6) and organic anion transporting polypeptides (OATP1B1 and OATP1B3) during pregnancy (nonpregnant (T0), first, second, and third (T3) trimester women; N = 3 each) and after administration of rifampicin (RIF) to healthy male subjects. Proteomic analysis revealed induction (mean fold-increase, 90% confidence interval) of sEV CYP3A4 after RIF 300 mg × 7 days (3.5, 95% CI = 2.5-4.5, N = 4, P = 0.029) and 600 mg × 14 days (3.7, 95% CI = 2.1-6.0, N = 5, P = 0.018) consistent with the mean oral midazolam area under the plasma concentration time curve (AUC) ratio in the same subjects (0.28, 95% CI = 0.22-0.34, P < 0.0001; and 0.17, 95% CI = 0.13-0.22, P < 0.0001). Compared with CYP3A4, liver sEV CYP3A5 protein (subjects genotyped CYP3A5*1/*3) was weakly induced (≤ 1.5-fold). It was also possible to measure liver sEV-catalyzed dextromethorphan (DEX) O-demethylation to dextrorphan (DXO), correlated with sEV CYP2D6 expression (r = 0.917, P = 0.0001; N = 10) and 3-hour plasma DXO-to-DEX concentration ratio (r = 0.843, P = 0.002, N = 10), and show that CYP2D6 was not induced by RIF. Nonparametric analysis of liver sEV revealed significantly higher CYP3A4 (3.2-fold, P = 0.003) and CYP2D6 (3.7-fold, P = 0.03) protein expression in T3 vs. T0 women. In contrast, expression of both OATPs in liver sEV was unaltered by RIF administration and pregnancy.
从使用新型两步方案从小套储存的血清样本中制备的肝源性小细胞外囊泡 (sEV) 被用作液体活检,以研究细胞色素 P450 (CYP3A4、CYP3A5 和 CYP2D6) 和有机阴离子转运多肽 (OATP1B1 和 OATP1B3) 在妊娠期间 (非妊娠 (T0) 、第一、二和第三 (T3) 孕期妇女;每组各 3 例,N=3) 和健康男性受试者给予利福平 (RIF) 后的诱导情况。蛋白质组学分析显示,RIF 300mg×7 天后 (3.5,95%CI=2.5-4.5,N=4,P=0.029) 和 600mg×14 天后 (3.7,95%CI=2.1-6.0,N=5,P=0.018) 肝 sEV CYP3A4 的诱导 (平均倍数增加,95%CI)与同一受试者中口服咪达唑仑的平均 AUC 比值一致 (0.28,95%CI=0.22-0.34,P<0.0001;和 0.17,95%CI=0.13-0.22,P<0.0001)。与 CYP3A4 相比,肝 sEV CYP3A5 蛋白 (对 CYP3A5*1/*3 进行基因分型的受试者) 诱导较弱 (≤1.5 倍)。还可以测量肝 sEV 催化的右美沙芬 (DEX) O-去甲基化为右啡烷 (DXO),与 sEV CYP2D6 表达相关 (r=0.917,P=0.0001;N=10) 和 3 小时血浆 DXO-to-DEX 浓度比 (r=0.843,P=0.002,N=10),并表明 RIF 不会诱导 CYP2D6。对肝 sEV 的非参数分析显示,T3 期妇女的 CYP3A4 (3.2 倍,P=0.003) 和 CYP2D6 (3.7 倍,P=0.03) 蛋白表达明显高于 T0 期妇女。相比之下,RIF 给药和妊娠均未改变肝 sEV 中两种 OATP 的表达。